Your browser doesn't support javascript.
loading
A Review on the Sources, Structures, and Pharmacological Activities of Lucidenic Acids.
Zheng, Chengwen; Rangsinth, Panthakarn; Shiu, Polly H T; Wang, Wen; Li, Renkai; Li, Jingjing; Kwan, Yiu-Wa; Leung, George P H.
Afiliación
  • Zheng C; Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China.
  • Rangsinth P; Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China.
  • Shiu PHT; Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China.
  • Wang W; Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China.
  • Li R; Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China.
  • Li J; Department of Rehabilitation Sciences, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, Hong Kong SAR, China.
  • Kwan YW; School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Leung GPH; Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China.
Molecules ; 28(4)2023 Feb 12.
Article en En | MEDLINE | ID: mdl-36838743
Ganoderma lucidum has long been used as a multi-purpose plant and functional food. The pharmacological properties of G. lucidum are primarily attributed to its polysaccharides and triterpenoids. Ganoderic and lucidenic acids are the two major triterpenoids groups in G. lucidum. Despite the discovery of 22 types of lucidenic acids, research on lucidenic acids is significantly less extensive compared to that on ganoderic acid. To the best of our knowledge, for the first time, in this review, we aimed to summarize the sources, contents, chemical structures, and pharmacological effects, including anti-cancer, anti-inflammatory, antioxidant, anti-viral, neuroprotective, anti-hyperlipidemic, anti-hypercholesterolemic, and anti-diabetic properties, of lucidenic acids. Studies on lucidenic acids are still preliminary and have several limitations. Therefore, more in-depth studies with optimal designs are essential for the development of lucidenic acids as medicines, functional foods, and nutraceuticals.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Triterpenos / Reishi Idioma: En Revista: Molecules Asunto de la revista: BIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Triterpenos / Reishi Idioma: En Revista: Molecules Asunto de la revista: BIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China